Jinesh Gandhi Sandipan Pal

Similar documents
Jinesh Gandhi Sandipan Pal

Jinesh Gandhi Sandipan Pal

Hardick Bora

Sanjay Jain Pavas Pethia

Stress test: Weak capital servicing ratios to drive pricing discipline

Niket Shah

CMP: INR350 TP: INR375 Downgrade to Neutral

Sohail Halai Alpesh Mehta

Jinesh Gandhi Chirag Jain

Sandipan Pal QFY13 Results Update Sector: Real Estate Unitech CMP: INR29 TP: INR44 Buy

Birla Corporation. CMP: INR216 TP: INR277 Buy

Idea Cellular. CMP: INR159 TP: INR200 Buy

NTPC CMP: INR169 TP: INR191 Buy

Pidilite Industries. CMP: INR164 TP: INR186 Buy

Siddharth Bothra

Larsen & Toubro. CMP: INR1,160 TP: INR1,417 Buy

Titan Industries. CMP: INR222 TP: INR220 Neutral

BGR Energy. CMP: INR282 TP: INR253 Neutral

CMP: INR121 TP: INR193 Buy

Hardick Bora 4QCY12 Results Update Sector: Healthcare Sanofi India CMP: INR2,307 TP: INR2,015 Neutral

Reliance Infrastructure CMP: INR528

Jaypee Infratech. CMP: INR33 TP: INR45 Buy

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy

Unitech. CMP: INR20 TP: INR30 Buy

BGR Energy. CMP: INR266 TP: INR230 Neutral

Jinesh Gandhi Chirag Jain

Jubilant Foodworks. CMP: INR1,189 TP: INR1,0541,054 Neutral

Canara Bank. CMP: INR419 TP: INR525 Buy

Coal India CMP: INR348 TP: INR408 Buy

IndusInd Bank. CMP: INR345 TP: INR419 Buy

Godawari Power & Ispat

BGR Energy. CMP: INR284 TP: INR296 Neutral

Jaiprakash Associates

Idea Cellular. CMP: INR81 TP: INR Under Review

Shree Renuka Sugars. CMP: INR26 TP: INR45 Buy

Godrej Consumer Products

Sanofi India. CMP: INR2,200 TP: INR1,848 Neutral

IDBI Bank. CMP: INR106 TP: INR121 Neutral

Larsen & Toubro. CMP: INR1,278 TP: INR1,380 Buy

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy

Punjab National Bank. CMP: INR716 TP: INR950 Buy

Market share recovery, price hike, content leverage to drive growth

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

Hindalco. CMP: INR113 TP: INR151 Buy

Cross service charges at INR m/quarter

Urban demand revives; Akzo gaining market share

Hardick Bora QFY13 Results Update Sector: Healthcare Lupin CMP: INR725 TP: INR851 Buy

Petronet LNG. CMP: INR146 TP: INR205 Buy

Canara Bank. CMP: INR464 TP: INR645 Buy

Godrej Properties. CMP: INR368 TP: INR420 Neutral

Shoppers Stop. CMP: INR339 TP: INR355 Neutral

Hardick Bora 4QFY13 Results Update Sector: Healthcare Dr Reddy's Laboratories CMP: INR2,026 TP: INR2,375 Buy

Steel Authority of India

Alpesh Mehta Sohail Halai

Maruti Suzuki. CMP: INR1,395 TP: INR1,730 Buy

Strides Arcolab. CMP: INR717 TP: INR829 Buy

CPCB-2: Important long-term driver

Cement. Demand to grow 8%, with cost push to be passed on CCI probe to have limited impact

M&M Financial Services

Gautam Duggad Sreekanth P V S

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral

Just Dial. CMP: INR1,129 TP: INR1,475 Buy

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat

Monnet Ispat. CMP: INR449 TP: INR518 Neutral

Cummins India. CMP: INR430 TP: INR462 Neutral

CMP: INR124 TP: INR172 Buy. Benefit of two major motorcycle launches not priced in. Improved industry outlook and recent launch success drive upgrades

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy

Oberoi Realty. CMP: INR269 TP: INR320 Buy

CMP: INR320 TP: INR164(-49%) Sell Intending to exit UK execution is key!

Automobiles. HMSI s expansion could result in short-term pressure on HMCL and BJAUT

Oberoi Realty. CMP: INR264 TP: INR315 Buy

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy

Punjab National Bank. CMP: INR768 TP: INR963 Buy

CMP: INR415 TP: INR 471 BUY

Torrent Pharmaceuticals

Tata Power. CMP: INR111 TP: INR92 Neutral

Dabur India. CMP: INR106 TP: INR94 Neutral

Dabur India. CMP: INR130 TP: INR135 Neutral

Jubilant Foodworks. CMP: INR1,051 TP: INR1,054 Neutral

Previous Recommendation: Buy

Shree Renuka Sugars. CMP: INR41 TP: INR50 Buy

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy

Expect capacity-led rerating; maintain Buy

Godrej Consumer Products

BHEL. CMP: INR227 TP: INR233 Neutral

Birla Corporation. CMP: INR484 TP: INR590 (+22%) Buy

Oberoi Realty. CMP: INR240 TP: INR297 Buy

Raymond. Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy. CMP: INR385 TP: INR462 Buy

Pantaloon Retail. CMP: INR177 TP: INR192 Neutral

CMP: INR475 TP: INR609 (+28%) Buy

India Cements. CMP: INR107 TP: INR113 (+6%) Neutral

Maruti Suzuki. CMP:Rs1,327 TP:Rs1,625 Buy

Godrej Properties. CMP: INR595 TP: INR635 Neutral

CMP: INR1,044 TP: INR970 (-7%) Neutral Sale of Healthcare business margin accretive

Hindustan Unilever. CMP:INR324 TP:INR302 Neutral

Sun Pharmaceuticals. CMP: INR554 TP: INR614 Neutral

ONGC. CMP: INR402 TP: INR485 Buy

ECOSCOPE. Real GDP growth eases on lower net indirect taxes. The Economy Observer. Real GVA growth exactly as expected

Synergy benefits can drive up to 14% EPS upgrade

Transcription:

BSE Sensex S&P CNX 19,576 5,944 Bloomberg GRASIM IN Equity Shares (m) 91.7 M.Cap. (INR b)/(usd b) 270.6/5.0 52-Week Range (INR) 3,511/2,216 1,6,12 Rel. Perf. (%) 2/-17/5 Financials & Valuation (INR b) Y/E March 2013 2014E 2015E Sales 276.4 285.3 331.2 EBITDA 56.6 60.2 74.8 Adj. PAT 35.6 36.0 49.1 Adj. EPS (INR) 278.7 290.3 400.9 EPS Gr. (%) -3.4 4.2 38.1 BV/Sh. (INR) 2,142 2,403 2,772 RoE (%) 13.0 12.1 14.5 RoCE (%) 18.1 18.0 20.4 Payout (%) 9.4 10.1 8.0 Valuations P/E (x) 10.6 10.2 7.4 P/BV (x) 1.4 1.2 1.1 EV/EBITDA (x) 6.8 6.4 4.7 EV/Ton (x) 139 115 93 6 May 2013 4QFY13 Results Update Sector: Cement Grasim Industries CMP: INR2,950 TP: INR3,747 Buy Results below expectations: Grasim Industries posted lower than expected numbers for 4QFY13. Net sales declined 1% YoY (grew 13% QoQ) to INR13.8b (v/s our estimate of INR12.4b), EBITDA was flat YoY/QoQ at INR2.14b and PAT was down 13% YoY (~7.5% QoQ) to INR2.1b. EBITDA margin contracted 210bp QoQ (flat YoY) to 15.6% (v/s our estimate of 20.6%). Reported PAT of INR3.72b includes ~INR2.04b of profit on sale of its 15% stake in Alexandria Carbon Black and 2.75% stake in Thai Carbon Black to another AV Birla Group company. Terrace Bay losses impact consolidated performance: Consolidated net sales grew 5% YoY to INR75.5b. EBITDA declined 3.4% YoY to INR13.7b, with EBITDA margin contracting 170bp YoY to 19.3%. VSF PBIDT was INR2.04b (v/s INR1.62b in 3QFY12 and INR2.51b in 4QFY12), impacted by decline in realizations. Grasim's proportionate PBIDT losses at Terrace Bay (Canada) for 4QFY13/FY13 were INR273.1m/INR602.1m. Consolidated PAT grew 1% YoY to INR8.2b. VSF margins remain under pressure: VSF business volumes were in line, with 0.3% YoY growth to 95,161 tons (v/s estimate of 95,071 tons). Realizations declined 2% YoY/QoQ to INR119/kg (v/s estimate of INR120.5/kg). Weak realizations coupled with higher caustic soda prices impacted PBITDA margin, which declined 50bp QoQ and 110bp YoY to 17.8% (v/s estimate of 18.6%). Downgrading estimates; maintain Buy: We are downgrading our consolidated EPS estimates for FY14/FY15 by 14.3%/6.6% to INR290/INR401 to factor in weak realization trend in both VSF and Cement business. The stock trades at 7.4x FY15E consolidated EPS of INR401, 1x FY15E BV, and implied valuations of ~USD92/ton. The board has maintained dividend at INR22.5/share. Maintain Buy with a target price of INR3,747. Jinesh Gandhi (Jinesh@MotilalOswal.com) + 91 22 3982 5416 Sandipan Pal (Sandipan.Pal@MotilalOswal.com); +9122 3982 5436 1 Investors are advised to refer through disclosures made at the end of the Research Report.

Standalone EBITDA below estimates; non-core divestments boost PAT Net sales down 1% YoY (+13% QoQ) to INR13.8b (v/s est INR12.4b), EBITDA flat YoY/QoQ to INR2.14b and PAT down 13% YoY (~7.5% QoQ) to INR2.1b. EBITDA margin declined by 210bp QoQ (flat YoY) to 15.6% (v/s est 20.6%). It accounted for ~INR2.04b of profit on sale of its 15% stake in Alexandria Carbon Black Co and 2.75% stake in Thai Carbon Black to another A.V.Birla Group company. As a result, reported PAT was higher at INR3.72b. Consolidated net sales grew by 5% to INR75.5b, with EBITDA margin decline of 170bp YoY to 19.3%, EBITDA de-growth of 3.4% YoY to INR13.7b and PAT growth of 1% YoY to INR8.2b. Consolidated performance was impacted by ~INR240m PBIDT loss in Terrace Bay. Snapshot of consolidated performance (INR m) 4QFY13 4QFY12 % YoY 3QFY13 % QoQ Net Sales 75,525 72,067 4.8 67,292 12.2 EBITDA 14,585 15,100-3.4 12,564 16.1 EBIDT Margins (%) 19.3 21.0-160bp 18.7 60bp Adj.PAT 8,176 8,088 1.1 5,492 48.9 Adj. EPS (INR) 89.1 88.2 1.1 59.8 49.0 Source: Company, MOSL VSF business pressure on pricing continues VSF business volumes were in-line with 0.3% YoY growth to 95,161 tons (v/s est 95,071 tons). VSF realizations declined 2% YoY/QoQ to INR119/Kg (v/s est INR120.5/Kg). Weak realizations coupled with higher caustic prices impact PBITDA margins into 17.8% (-50bp QoQ v/s -110bp YoY v/s est 18.6%). On consolidated basis, PBIDT was at INR2.04b (v/s INR1.62b in 3QFY12 v/s INR2.51b in 4QFY12) was impacted YoY by decline in realizations. Grasim's proportionate losses at recently acquired pulp JV, AV Terrace Bay (Canada) for 4QFY13/FY13 were INR273.1m/INR602.1m. AV Terrace Bay, the pulp JV acquired in 2QFY13 with Grasim holding a 40%, commenced operations in Oct-12, as planned. Its losses are expected to reduce and converted into profit in a phased manner through mill up-gradation and cost optimization. VSF business performance 4QFY13 4QFY12 % YoY 3QFY13 % QoQ Production (ton) 85,992 83,349 3.2 88,297-2.6 Sales volume (ton) 95,161 94,904 0.3 78,579 21.1 Net Turnover (INR m) 12,164 12,279-0.9 10,299 18.1 Avg Realizations (INR/ton) 119,150 121,293-1.8 121,668-2.1 PBIDT Margin (%) 17.8 18.9-110bp 18.3-50bp PBDIT (INR m) 2,160 2,320-6.9 1,880 14.9 Source: Company, MOSL 6 May 2013 2

Trend in VSF business volumes and realizations Trend in VSF business EBITDA Source: Company, MOSL Limited downside to pricing, upside dependent on cotton outlook and Chinese players rationality The management has indicated that amidst challenging near-term, it doesn't see any further downside to VSF pricing, as at current global VSF prices Chinese players would be making losses. The management indicated that current VSF pricing is slightly lower than 4QFY13 average pricing. Chinese players are operating at 65-68% utilizations. Hence it doesn't expect any further decline in VSF prices globally. While surplus capacity at China remains major overhang on margins, the outlook of cotton crop and rationality of Chinese players would be key to VSF pricing. Abnormally deficient rains in Karnataka, production at Harihar is likely to be impacted intermittently from February onwards till onset of monsoons, having impact of 40-50 operating days between Feb-Jul'13. VSF worst is over; investing aggressively to consolidate leadership in both businesses; Capex plan on schedule; new capex of INR2.2b for Epoxy plant at Vilayat; VSF Outlook: Given the prevailing global economic conditions, coupled with the surplus capacity in China, the VSF industry is expected to remain under pressure in the short term. Despite recent improvement in cotton prices, VSF prices currently are subdued. Given the fragile global economy, recovery of textile sector is expected to be slow in near term. Present market conditions will require balancing between volumes and prices for expanded capacity. Its capex program to add ~156,500 ton is on track, with Harihar brownfield addition of 36,000 commissioning operations, whereas Vilayat Greenfield addition of 120,000 units by 2QFY14. Further, it is investing INR2.38b for setting up an Epoxy plant (51,500 TPA) at Vilayat, expected to be operational in 3QFY14. It plans to set-up Greenfield VSF capacity in Turkey through JV with other promoter owned companies (33% stake for INR567m). The JV has acquired requisite land and is in process of getting regulatory approvals including environment clearance. Also, it is capacity expansion of pulp capacity in Domsjo by 45,000 tons to 255,000 tons completed during 4QFY13 and is in under stabilization phase. Cement Outlook: In Cement, the demand is expected to grow by an average 8% in the long term with housing, infrastructure and allied spending being the key 6 May 2013 3

value drivers. Industry capacity utilization is likely to improve to 80% in FY 2016 as the pace of capacity addition will slow down. Cost pressures are easing off with the decline in global commodity prices, particularly energy. It is setting-up 9.2MT capacity at Chhattisgarh and Karnataka, along with with split grinding units, split grinding units and packaging terminals. This capacity would be entirely operational by 1HFY14. It has already commenced Clinkerization unit of 3.3MT at Chhattisgarh, grinding units of 1.55MT and 0.6MT in Maharashtra and Gujarat, taking total cement capacity to 50.9MT. The board has approved fresh brownfield capacity addition of 2.9mt at Rajasthan (incl 2 split grinding units) with capex of INR20b and commissioning by Mar-15, taking total capacity in India to 61.45mt. Total cement capex for the above stood at INR114b (INR40.6b in FY14) Capex of ~INR53b in FY14 both cement and VSF business (INR Cr) Valuation and view We are downgrading FY14/15 EPS consol estimates by 14.3%/6.6% to INR290/INR401, to factor in weak realization trend in both VSF and Cement business (Ultratech EPS downgraded by 18%/10% for FY14/15). VSF business is expected to have bottomed-out on pricing and profitability; however recovery would be function of demand recovery and/or competing fibre pricing (which are at unsustainable levels). Cement business outlook is improving with expected improvement in demand and pricing. Further, its aggressive capex plan of investing INR86b over FY14-16 endorses our long term positive outlook for both the businesses. The stock trades at 7.4x FY15 Consol EPS of INR401, and 1.1x P/B and implied valuations of ~USD93/ton. Maintain Buy with target price of INR3,747 (SOTP based, valuing economic interest in cement business at 9x EV/EBITDA & 20% hold-co discount and VSF at 4x EV/ EBITDA). 6 May 2013 4

Grasim (Consolidated): Revised forecast (INR b) FY14E FY15E Rev Old Chg (%) Rev Old Chg (%) Net Sales 285.3 296.6-3.8 331.2 341.7-3.1 Net Profit 26.6 31.1-14.2 36.8 39.4-6.5 EPS (INR) 290.3 338.6-14.3 400.9 429.3-6.6 Source: MOSL Grasim: SOTP based fair value (INR m) Parameter Multiple FY14E FY15E Standalone VSF business EV/EBITDA (x) 4 41,340 49,859 UltraTech Cement @ 60.3% EV/EBITDA (x) 9 207,140 261,406 (post 20% holdco discount) Total EV 248,481 311,265 Less: Gross Debt (incl pro-rata in subs) 60,551 57,536 Add: Cash & liquid invest 37,534 59,311 Add: Group holdings @ 20% discount 30,590 30,590 Total Equity Value 256,054 343,630 Fair value (INR/sh) post demerger 2,792 3,747 Source: MOSL Implied Hold-co discount FY14E FY15E CMP 2,950 2,950 Market Cap 270,579 270,579 Add: Net Debt -7,573-32,365 EV 263,006 238,214 Less: EV of VSF @ 4x EV/EBITDA 41,340 49,859 Implied EV of Cement 221,666 188,355 Implied EV/EBITDA (x) 7.7 5.2 Implied EV/Ton (USD) 113 93 Implied Discount to UltraTech on replacement cost (%) 27 37 ACC/Ambuja on replacement cost (%) 15 28 UltraTech on EV/EBITDA (%) 26 36 ACC/Ambuja on EV/EBITDA (%) 22 42 Source: MOSL 6 May 2013 5

Grasim Industries: an investment profile Company description Grasim is a diversified company with cement and VSF being core business, accounting for 65% and 35% of revenues (post-restructuring). Its other business includes chemicals and textiles. The acquisition of UltraTech Cement, the cement division of L&T, by Grasim catapulted it to number one position in the Indian cement industry with total capacity under control of 51mt. Key investment argument Being largest player with total capacity of 51MT (existing capacity) under control and highest organic growth visibility, Grasim would be biggest beneficiary of any further increase in cement price. Global leader in VSF business, with backward integration in pulp, experiencing robust demand in both global and domestic markets. Key investment risks Cement sector is likely to add huge capacities in coming year which can result in significant volatility in cement prices. Declining competing fibre prices coupled with increasing cost would put pressure on VSF business profitability Recent development The board has maintained dividend at INR22.5/share. Valuation and view The stock trades at 7.4x FY15 Consol EPS of INR401, and 1.1x P/B and implied valuations of ~USD93/ton. Maintain Buy with target price of INR3,747 (SOTP based, valuing economic interest in cement business at 9x EV/EBITDA & 20% hold-co discount and VSF at 4x EV/EBITDA). Sector view We believe we have already witnessed bottom-ofthe-cycle utilization & profitability, and it should gradually improve hereon given sustainable demand drivers. Structural increase in cost base would necessitate higher cement prices. Continued revival in cement demand, witnessed in 2HFY12, would be key catalyst for the stock performance. Comparative valuations Grasim ACC ACEM P/E (x) FY14E 10.2 17.9 18.8 FY15E 7.4 19.3 18.5 P/BV (x) FY14E 1.2 3.1 3.3 FY15E 1.1 3.0 3.0 EV/Ton (USD) FY14E 115 119 165 FY15E 93 113 153 EV/EBITDA (x) FY14E 6.4 10.0 9.9 FY15E 4.7 10.1 9.7 EPS: MOSL forecast v/s consensus (INR) MOSL Consensus Variation Forecast Forecast (%) FY14 290.3 333.6-13.0 FY15 400.9 391.5 2.4 Target price and recommendation Current Target Upside Reco. Price (INR) Price (INR) (%) 2,950 3,747 27 Buy Stock performance (1 year) Shareholding pattern (%) Mar-13 Dec-12 Mar-12 Promoter 25.5 25.5 25.6 Domestic Inst 15.4 15.4 16.9 Foreign 41.1 39.7 38.6 Others 18.0 19.3 19.0 6 May 2013 6

Financials and Valuation 6 May 2013 7

Disclosures This report is for personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement Grasim Industries 1. Analyst ownership of the stock No 2. Group/Directors ownership of the stock No 3. Broking relationship with company covered No 4. Investment Banking relationship with company covered No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Nihar Oza Kadambari Balachandran Email: niharoza.sg@motilaloswal.com Email : kadambari.balachandran@motilaloswal.com Contact: (+65) 68189232 Contact: (+65) 68189233 / 65249115 Office address: 21 (Suite 31), 16 Collyer Quay, Singapore 049318 Motilal Oswal Securities Ltd Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai 400 025 Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com